Vaccines· 2026Q1
Cellular and Humoral Immune Responses in Anti-N Seropositive and Seronegative Vaccinated Participants: Insights from the Bialystok PLUS Study
- 0citations
- Q1SCImago
- 2026year
Short summary
Vaccinated individuals with prior SARS-CoV-2 infection (anti-N seropositive) showed a 3.57-fold higher cellular immune response compared to those without prior infection (anti-N seronegative).
AI-generated from the title and abstract; the full text is not read.
Key points
- Vaccinated participants with prior SARS-CoV-2 infection (anti-N seropositive) had significantly higher cellular immune responses (median 1752.3 vs. 771.1, p < 0.001).
- Anti-N seropositivity was independently associated with a 3.57-fold higher cellular immune response after adjusting for age and sex.
- Anti-S antibody levels showed moderate positive correlations with cellular response in both seropositive and seronegative groups.
- Routine laboratory parameters were not significantly associated with cellular immune response.
AI-generated from the title and abstract; the full text is not read.
Abstract
Background: In the post-pandemic era, SARS-CoV-2 immunity is increasingly shaped by vaccination and previous infection. Understanding the relationship between cellular and humoral immune responses is important for characterizing immunity in vaccinated populations. Methods: This study included 629 participants from the Bialystok PLUS cohort, stratified according to anti-N serostatus into anti-N-seronegative (n = 159) and anti-N-seropositive (n = 470) groups. Cellular immune response measurements were available for a subset of 246 participants. Humoral response was assessed using anti-S and anti-N antibodies, while cellular response (OC) was evaluated by interferon-gamma (IFN-γ) release following SARS-CoV-2 antigen stimulation. Group differences were assessed using the Mann–Whitney U test, and associations were evaluated using Spearman’s rank correlations with Benjamini–Hochberg correction. Multivariable linear regression was used to assess the association between anti-N serostatus and cellular response after adjustment for age and sex. Results: Anti-N-seropositive participants had significantly higher cellular responses than anti-N-seronegative participants (median 1752.3 vs. 771.1; p < 0.001). After adjustment for age and sex, anti-N seropositivity remained significantly associated with higher cellular response, corresponding to a 3.57-fold higher geometric mean of OC + 1 (95% CI: 1.90–6.73; p < 0.001). Anti-S antibody levels showed moderate positive correlations with cellular response in both anti-N-seronegative and anti-N-seropositive participants (ρ = 0.45 and ρ = 0.37, respectively), and the association remained significant after adjustment for age, sex, and anti-N serostatus. No significant associations were observed between cellular response and anti-N antibody levels or routine laboratory parameters after correction for multiple comparisons. Conclusions: Anti-N seropositivity was associated with higher SARS-CoV-2-specific cellular immune response among vaccinated participants, and this association remained significant after adjustment for age and sex. The moderate association between anti-S antibody levels and cellular response suggests that humoral and cellular measures provide related but complementary information on SARS-CoV-2-specific immunity. Routine laboratory parameters were not significantly associated with cellular immune response in this cohort.
The authors' abstract, as published at the source. Vaccines, 2026 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Infectious Diseases
Infectious DiseasesMedicine